Clinical Trials Directory

Trials / Unknown

UnknownNCT05469321

Neurological Impairment in a Young Population Exposed to Recreational Nitrous Oxide

A Retrospective Study of Neurological Impairment in a Young Population Exposed to Recreational Nitrous Oxide

Status
Unknown
Phase
Study type
Observational
Enrollment
20 (estimated)
Sponsor
Centre Hospitalier Universitaire de Nīmes · Academic / Other
Sex
All
Age
15 Years
Healthy volunteers
Not accepted

Summary

Nitrous oxide (N2O) is a colorless, flammable, analgesic gas used in surgery and dentistry. The consumption of N2O has increased among young French people aiming to relax because of its short-lived neuropsychological effect (euphoria, depersonalization, analgesia) and its wide availability on the market. It can be responsible in case of prolonged use and overdose of a vitamin B12 deficiency with possible neuropsychiatric complications: sensitivomotor neuropathy, myelopathy, behavioral and cognitive disorders of acute or sub-acute installation. N2O inhibits the activitý of methionine synthase, decreases the activitý of methylmalonyl-CoA mutase leading to vitamin B12 deficiency but in addition to the interference with vitamin B12 metabolism there seems to be a direct toxicity of N20. Myelin alteration was the typical electromyography finding but new axonal profiles were also described. Since myelopathy affects both the posterior and lateral cords, combined spinal cord sclerosis is the most common location of injury associated with N2O intoxication.

Conditions

Interventions

TypeNameDescription
OTHERNone, pure observationnal studyNone, pure observational study following the usual management of the patients

Timeline

Start date
2022-08-22
Primary completion
2024-12-01
Completion
2024-12-01
First posted
2022-07-21
Last updated
2024-01-16

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05469321. Inclusion in this directory is not an endorsement.